Cargando…
A review for cell-based screening methods in drug discovery
With the biological relevance of the whole cells, low cost compared with animal experiments, a wide variety of cell-based screening platforms (cell-based assay, cell-based microfluidics, cell-based biosensor, cell-based chromatography) have been developed to address the challenges of drug discovery....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biophysics Reports Editorial Office
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210057/ https://www.ncbi.nlm.nih.gov/pubmed/37288368 http://dx.doi.org/10.52601/bpr.2021.210042 |
_version_ | 1785046993122361344 |
---|---|
author | Wei, Fen Wang, Sicen Gou, Xilan |
author_facet | Wei, Fen Wang, Sicen Gou, Xilan |
author_sort | Wei, Fen |
collection | PubMed |
description | With the biological relevance of the whole cells, low cost compared with animal experiments, a wide variety of cell-based screening platforms (cell-based assay, cell-based microfluidics, cell-based biosensor, cell-based chromatography) have been developed to address the challenges of drug discovery. In this review, we conclude the current advances in cell-based screening and summary the pros and cons of the platforms for different applications. Challenges and improvement strategies associated with cell-based methods are also discussed. |
format | Online Article Text |
id | pubmed-10210057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Biophysics Reports Editorial Office |
record_format | MEDLINE/PubMed |
spelling | pubmed-102100572023-06-07 A review for cell-based screening methods in drug discovery Wei, Fen Wang, Sicen Gou, Xilan Biophys Rep Review With the biological relevance of the whole cells, low cost compared with animal experiments, a wide variety of cell-based screening platforms (cell-based assay, cell-based microfluidics, cell-based biosensor, cell-based chromatography) have been developed to address the challenges of drug discovery. In this review, we conclude the current advances in cell-based screening and summary the pros and cons of the platforms for different applications. Challenges and improvement strategies associated with cell-based methods are also discussed. Biophysics Reports Editorial Office 2021-12-31 /pmc/articles/PMC10210057/ /pubmed/37288368 http://dx.doi.org/10.52601/bpr.2021.210042 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Wei, Fen Wang, Sicen Gou, Xilan A review for cell-based screening methods in drug discovery |
title | A review for cell-based screening methods in drug discovery |
title_full | A review for cell-based screening methods in drug discovery |
title_fullStr | A review for cell-based screening methods in drug discovery |
title_full_unstemmed | A review for cell-based screening methods in drug discovery |
title_short | A review for cell-based screening methods in drug discovery |
title_sort | review for cell-based screening methods in drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210057/ https://www.ncbi.nlm.nih.gov/pubmed/37288368 http://dx.doi.org/10.52601/bpr.2021.210042 |
work_keys_str_mv | AT weifen areviewforcellbasedscreeningmethodsindrugdiscovery AT wangsicen areviewforcellbasedscreeningmethodsindrugdiscovery AT gouxilan areviewforcellbasedscreeningmethodsindrugdiscovery AT weifen reviewforcellbasedscreeningmethodsindrugdiscovery AT wangsicen reviewforcellbasedscreeningmethodsindrugdiscovery AT gouxilan reviewforcellbasedscreeningmethodsindrugdiscovery |